Wave Life Sciences Ltd.
WVE
7 insider filings · Latest: Mar 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Aug 14 1:00 AM | Heidi L WagnerDirector | Sale | 7,000 | $6.01 | $42.1K | 44,930(D) | View → |
| Aug 12, 2026 | Aug 14 1:00 AM | Adrian RawcliffeDirector | Sale | 12,700 | $5.29 | $67.2K | 0(D) | View → |
| Aug 11, 2026 | Aug 14 1:00 AM | Ken TakanashiDirector | Sale | 3,864 | $6.01 | $23.2K | 20,079(D) | View → |
| Aug 11, 2026 | Aug 14 1:00 AM | Aik Na TanDirector | Sale | 432 | $6.01 | $2.6K | 24,968(D) | View → |
| Aug 12, 2026 | Aug 12 8:32 PM | ADRIAN G RAWCLIFFE | Proposed Sale | 12,700 | $5.05 | $64.1K | — | View → |
| Aug 11, 2026 | Aug 11 8:30 PM | HEIDI L WAGNER | Proposed Sale | 7,000 | $6.07 | $42.5K | — | View → |
| Mar 30, 2026 | Mar 31 12:30 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 971,091 | $6.50 | $6.3M | 26,975,505(I) | View → |
| Mar 27, 2026 | Mar 31 12:30 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,495,623 | $6.43 | $16.0M | 26,004,414(I) | View → |
| Mar 26, 2026 | Mar 31 12:30 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 5,305,782 | $6.08 | $32.3M | 23,508,791(I) | View → |
| Feb 26, 2026 | Feb 28 2:00 AM | Chris FrancisSVP, Corporate Development, Head of Emerging Areas | Sale | 33,194 | $15.05 | $499.6K | 61,867(D) | View → |
| Feb 9, 2026 | Feb 12 2:03 AM | Kyle MoranChief Financial Officer | Sale | 3,588 | $13.45 | $48.3K | 134,385(D) | View → |
| Feb 9, 2026 | Feb 12 2:02 AM | Paul BolnoDirector, President and CEO | Sale | 10,480 | $13.45 | $141.0K | 275,520(D) | View → |
| Feb 9, 2026 | Feb 12 2:01 AM | Chris FrancisSVP, Corporate Development, Head of Emerging Areas | Sale | 1,883 | $13.45 | $25.3K | 61,867(D) | View → |
| Feb 9, 2026 | Feb 12 2:00 AM | Chandra VargeeseChief Technology Officer, Head of Platform Discovery Sciences | Sale | 3,228 | $13.45 | $43.4K | 408,246(D) | View → |
| Feb 9, 2026 | Feb 10 2:30 AM | KYLE MORAN | Proposed Sale | 3,564 | $13.45 | $47.9K | — | View → |
| Feb 9, 2026 | Feb 10 2:29 AM | Chris Francis | Proposed Sale | 1,870 | $13.45 | $25.2K | — | View → |
| Feb 9, 2026 | Feb 10 2:27 AM | PAUL BOLNO | Proposed Sale | 10,411 | $13.45 | $140.0K | — | View → |
| Dec 9, 2025 | Dec 9 9:24 PM | KYLE MORAN | Proposed Sale | 86,000 | $18.52 | $1.6M | — | View → |
| Dec 8, 2025 | Dec 9 12:08 AM | Henry Family Trust | Proposed Sale | 93,445 | $18.52 | $1.7M | — | View → |
| Dec 8, 2025 | Dec 8 9:39 PM | HEIDI L WAGNER | Proposed Sale | 14,000 | $7.49 | $104.9K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Aug 14 1:00 AM | Heidi L WagnerDirector | Option Exercise | 7,000 | $5.97 | 0(D) | View → |
| Mar 23, 2026 | Mar 26 8:15 PM | Ken TakanashiDirector | Conversion | 3,901,348 | — | 0(I) | View → |
| Feb 26, 2026 | Feb 28 2:00 AM | Chris FrancisSVP, Corporate Development, Head of Emerging Areas | Option Exercise | 33,194 | $4.75 | 61,175(D) | View → |
| Feb 5, 2026 | Feb 12 2:03 AM | Kyle MoranChief Financial Officer | Grant/Award | 273,750 | $12.75 | 273,750(D) | View → |
| Feb 5, 2026 | Feb 12 2:02 AM | Paul BolnoDirector, President and CEO | Grant/Award | 1,000,000 | $12.75 | 1,000,000(D) | View → |
| Feb 5, 2026 | Feb 12 2:01 AM | Chris FrancisSVP, Corporate Development, Head of Emerging Areas | Grant/Award | 232,500 | $12.75 | 232,500(D) | View → |
| Feb 5, 2026 | Feb 12 2:00 AM | Chandra VargeeseChief Technology Officer, Head of Platform Discovery Sciences | Grant/Award | 273,750 | $12.75 | 273,750(D) | View → |